Revenue: The sum of all revenue fields included for a company's operating activities.
RegeneRx Biopharmaceuticals Inc. (RGRX) had Revenue of $0.08M for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
|
Revenue |
$0.08M |
$-1.73M |
|
-- |
|
$0.08M |
|
$1.48M |
|
$-1.40M |
|
$-0.33M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.73M |
|
$-1.40M |
|
$-1.40M |
|
1.44M |
|
1.44M |
|
$-1.00 |
|
$-1.00 |
|
| Balance Sheet Financials | |
$0.31M |
|
-- |
|
$0.08M |
|
$0.38M |
|
$0.55M |
|
$1.37M |
|
$3.27M |
|
$3.83M |
|
$-3.45M |
|
$-3.45M |
|
$-3.45M |
|
1.44M |
|
| Cash Flow Statement Financials | |
$-0.94M |
|
-- |
|
-- |
|
$1.23M |
|
$0.29M |
|
$-0.94M |
|
$0.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.55 |
|
-- |
|
-- |
|
-0.66 |
|
-0.40 |
|
100.00% |
|
-1826.44% |
|
-1826.44% |
|
-1826.44% |
|
-2250.43% |
|
-2250.43% |
|
$-0.94M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
-- |
|
-- |
|
-- |
|
50.14% |
|
50.14% |
|
-452.00% |
|
83.34% |
|
$-2.40 |
|
$-0.66 |
|
$-0.66 |
|